Data from the study show that EndeavorRx treatment resulted in increased brain activity related to attention function, as measured by EEG.
The virtual reality solution tracks user progress by measuring sustained focus when distractions are present.
With this program, regular educational messages are sent to parents during the first 30 days to provide them with information about ADHD and its treatment.
The STARS-ADHD trial will evaluate the safety and efficacy of the company's proprietary platform, Project: EVO, for the treatment of children with ADHD.
QbCheck provides unbiased and objective outcome measurements that can be utilized quickly and easily so that professionals are informed to act in ADHD.
Developed by Akili Interactive Labs, Project: EVO was designed to assess and treat cognitive issues; it adapts the intensity of the game to the player.